Disseminated Cutaneous Mycobacterium Chelonae Infection

Charles L. Kane, MPH, Albert L.Vincent, PhD, John N. Greene, MD, and Ramon L. Sandin, MD, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Fla.

Disclosures

Cancer Control. 2000;7(2) 

In This Article

Conclusions

Our immunocompromised patient exhibited the classic presentation of a chronic, indolent course of cutaneous infection caused by rapidly growing mycobacterium. Lack of response to conventional antibiotics and the nodular or ulcerative appearance suggest a mycobacterial or fungal etiology or fungal etiology. Impairment of cell-mediated immunity, such as with corticosteroids, should further raise suspicion of these latter two possibilities. Once the infection is identified as a mycobacteria, specification and susceptibility testing should be performed to guide therapy. In vitro antibiotic susceptibility testing is helpful in directing effective treatment of M. chelonae-disseminated cutaneous infection.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....